NFSG
PTPI

Newbridge Financial Services Group’s Petros Pharmaceuticals PTPI Stock Holding History

Newbridge Financial Services Group’s Portfolio PTPI Stock Details PTPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5
Closed -$178 – 1203
2024
Q1 		$178 Hold
5
– – ﹤0.01% 1130
2023
Q4 		$169 Hold
5
– – ﹤0.01% 1081
2023
Q3 		$208 Hold
5
– – ﹤0.01% 1238
2023
Q2 		$244 Buy
+5
New +$389 ﹤0.01% 1285
2022
Q4 		– Sell
-5
Closed -$1K – 1499
2022
Q3 		$1K Hold
5
– – ﹤0.01% 1328
2022
Q2 		$1K Hold
5
– – ﹤0.01% 1298
2022
Q1 		$2K Hold
5
– – ﹤0.01% 1311
2021
Q4 		$4K Hold
5
– – ﹤0.01% 1126
2021
Q3 		$2K Hold
5
– – ﹤0.01% 1194
2021
Q2 		$4K Buy
+5
New +$4K ﹤0.01% 1175

Other funds holding PTPI

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Newbridge Financial Services Group's PTPI Position: Q2 2024 in Review

Newbridge Financial Services Group sold out of Petros Pharmaceuticals (PTPI) in Q2 2024, closing a stake of 5 shares — an estimated $178 sold.

Newbridge Financial Services Group first reported a position in PTPI in Q2 2021 and held it in 10 quarters. The position peaked at $4K in Q4 2021. 11 funds tracked by Wall St. Rank hold PTPI as of Q2 2024.

  • Newbridge Financial Services Group reported no remaining Petros Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Newbridge Financial Services Group sold 5 Petros Pharmaceuticals shares in Q2 2024, an estimated $178.
  • Newbridge Financial Services Group first reported a position in Petros Pharmaceuticals in Q2 2021 and held it in 10 quarters.
  • Newbridge Financial Services Group's Petros Pharmaceuticals position peaked at $4K in Q4 2021.
  • 11 funds tracked by Wall St. Rank held Petros Pharmaceuticals as of Q2 2024.

Based on Newbridge Financial Services Group's 13F filing for Q2 2024, filed 11 Sep 2024.